Effect of ultrashort wave therapy on cytokine changes in patients with chronic obstructive pulmonary disease

孙强三,王伟,徐少华,王晓红,孙昭辉,徐青

DOI: https://doi.org/10.3321/j.issn:1673-8225.2004.06.050

2004-01-01

Abstract:Aim: To observe the effect of ultrashort wave therapy on the airway inflammation in patients with chronic obstructive pulmonary disease (COPD), and to explore the mechanism of ultrashort wave therapy in the treatment of COPD. Methods: Seventy-four patients with COPD of acute episode were randomly divided into 2 groups according to different treatment: ultrashort wave group (regular treatment + ultrashort wave therapy, n = 42 ) and control group (regular treatment, n = 32) . The courses, patients' condition and regular treatment were the same in the two groups. The level of interleukin-8 (IL-8), tumor necrosis factor-α (TNF-α) and granulocyte colony-stimulating factor (G-CSF) in serum of the two groups were tested before and after treatment respectively. Results: There were significant differences in the levels of IL-8 [(236.10 ± 52.60) ng/L and (197.90 ± 62.80) ng/L] and G-CSF [(120.75 ± 21.32) ng/L and(109.92 ± 22.96) ng/L] before and after treatment in the control group (t = 1.93, 1.95; P < 0.05 ), while the difference in TNF-α [(38.01 ± 7.10) pmol/L and(36.85 ± 4.08) pmol/L] was not significant (t = 1.47; P > 0.05) . There were significant differences in the levels of IL-8 [(232.36 ± 76.34) ng/L and(108.48 ± 40.50) ng/L], TNF-α [(39.96 ± 6.01) pmol/L and(27.50 ± 3.88) pmol/L] and G-CSF [(125.40 ± 21.93) ng/L and (96.52 ± 19.01) ng/L] before and after treatment in the ultrashort wave group (t = 1.92, 1.97, 1.89; P < 0.05), and were significantly different from those in the control group (t = 1.98, 1.87, 1.89; P < 0.05). Conclusion: Ultrashort wave therapy can improve the pulmonary function by reducing the airway inflammation in patients with COPD, is safe and effective to the COPD of acute episode.